Nonlinear response surface and mixture experiment methodologies applied to the study of synergism

Biometrical Journal

Volumn 46, Issue 1, 2004, Pages 56-71

  White, Donald B ^a   Faessel, Hélène M ^b,c   Slocum, Harry K ^b   Khinkis, Leonid ^b,d   Greco, William R ^b  

^a UNIVERSITY OF TOLEDO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d CANISIUS COLLEGE   (United States)

Author keywords

Antagonism; Mixture amount model; Nonlinear regression; Pharmacometrics; Process variable; Response surface; Synergism

Indexed keywords

NONLINEAR EQUATIONS;

ANTAGONISM; MIXTURE AMOUNT MODEL; MIXTURE EXPERIMENT; NON-LINEAR REGRESSION; NON-LINEAR RESPONSE; PHARMACOMETRICS; PROCESS VARIABLES; RESPONSE SURFACE; RESPONSE SURFACE MODELLING; SYNERGISM;

SURFACE PROPERTIES;

EID: 22144454082     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/bimj.200210002     Document Type: Article

References (35)

1. Alonso-Amelot, M. E. and Calcagno, M. P. (2000). Modeling synergistic and anagonistic interactions in xenobiotic compounds. Journal of Chemical Ecology 26(2), 513-531.
2. Atkinson, A. C. (1996). The usefulness of optimum experimental design. Journal of the Royal Statistical Society B, 58(1), 59-76.
3. Bezeau, M. and Endrenyi, L. (1986). Design of experiments for the precise estimation of dose-response parameters: the hill equation. Journal of Theoretical Biology 123, 415-430.
4. Carter, W. H. Jr., Gennings C., Staniswalis, J. G., Campbell, E. D. and White, K. L. Jr. (1988). A statistical approach to the construction and analysis of isobolograms. Journal of the American College of Toxicology 7(7), 963-973.
5. Carter, W. H. Jr. (1995). Relating isobolograms to response surfaces. Toxicology 105, 181-188.
6. Chan, L. Y., 2000: Optimal designs for experiments with mixtures: a survey. Communications in Statistics -Theory and Methods 29(9 & 10), 2281-2312.
7. Cornell, J. A. (1995). Fitting models to data from mixture experiments containing other factors. Journal of Quality Technology 27(1), 13-33.
8. Cornell, J. A. (2002). Experiments with Mixtures: Designs, Models, and the Analysis of Mixture Data, John Wiley and Sons, pp. 286-353.
9. Donev, A. N. (1989). Design of experiments with both mixture and qualitative factors. Journal of the Royal Statistical Society B 51(2), 297-302.
10. Faessel, H. M., Slocum, H. K., Rustum, Y. M., and Greco, W. R. (1999). Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6, 7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2, 5-thienoylamino-L-glutamic acid (AG2034): comparison across sensitive and resistant human tumor cell lines. Biochemical Pharmacology 57, 567-577.
11. Faessel, H. M., Slocum, H. K., Jackson, R. C., Boritzki, T. J., Rustum, Y. M., Nair, M. G. and Greco, W. R. (1998). Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation. Cancer Research 58, 3036-3050.
12. Gennings, C., Sophia, R. D., Carchman, R. A., Carter, W. H. Jr., and Swinyard, E. A. (1995). Analysis of anticolvulsant and neurotoxic responses to combination therapy with Carbamazepine, Felbamate and Phenytoin by response-surface modeling. Arzneimittel-Forschung/Drug Research 45(II,7), 739-748.
13. Gennings, C. (1995). An efficient experimental design for detecting departure from additivity in mixtures of many chemicals. Toxicology 105, 189-197.
14. Greco, W. R. (1989). Importance of the structural component of generalized nonlinear models for joint drug action, Proceedings of the Biopharmaceutical Section of the American Statistical Association, 183-188.
15. Greco, W. R. and Lawrence, D. D. (1988). Assessment of the degree of drug interaction where the response variable is discrete, Proceedings of the Biopharmaceutical Section of the American Statistical Association, 226-231.
16. Greco, W. R., Park, H. S., and Rustum, Y. M. (1990). Application of a new approach for the quantitation of drug synergism to combination of cis-diamminedichloroplatinum and l-_-D-arabinofuranosylcytosine. Cancer Research 50, 5318-5327.
17. Greco, W. R., Bravo, G., and Parsons, J. C. (1995). A search for synergy: a critical review from a response surface perspective. Pharmacological Reviews 47(2), 331-385.
18. Hewlett, P. S. (1969). Measurement of the potencies of drug mixtures. Biometrics 25, 477-487.
19. Hilgers, R. D. and Bauer, P. (1995). Optimal designs for mixture amount experiments. Journal of Statistical Planning and Inference 48, 241-246.
20. Hilgers, R. D. (1999). Design efficiency and estimation for component amount models. Biometrical Journal 41(7), 783-798.
21. Hill, A.V. (1910). The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. Journal of Physiology 40, iv-vii.
22. Kisliuk, R. L. (2000). Synergistic interactions among antifolates. Pharmacology and Therapeutics 85, 183-190.
23. Loewe, S. and Muischnek, H. (1926). Effect of combinations: mathematical basis of problem. Archives of Experimental Pathology Pharmakology 114, 313-326.
24. Machado, S.G. and Robinson, G. A. (1994). A direct, general approach based on isobolograms for assessing the joint action of drugs in preclinical experiments. Statistics in Medicine 13, 2289-2309.
25. Piepel, G. F. and Cornell, J. A. (1985). Models for mixture experiments when the response depends on the total amount. Technometrics 27(3), 219-227.
26. Piepel, G. F. (1988). A note on models for mixture-amount experiments when the total amount takes a zero value. Technometrics 30(4), 449-450.
27. Piepel, G. F. and Cornell, J. A. (1987). Designs for mixture-amount experiments. Journal of Quality Technology 19(1), 11-28.
28. Scheffé, H. (1958). Experiments with Mixtures. Journal of the Royal Statistical Society, Series B 20, 344-360.
29. Suhnel, J. (1992). Zero interaction response surfaces, interaction functions and difference response surfaces for combinations of biologically active agents. Arzneimittel-Forschung/Drug Research 42-2(10), 1251-1258.
30. Syracuse, K. C. and Greco, W. R. (1986). Comparison between the method of Chou and Talalay and a new method for the assessment of the combined effects of drugs: a Monte-Carlo simulation study. American Statistical Association Proceedings of the Biopharmaceutical Section, 127-132.
31. Tallarida, R. J., Stone, D. J. Jr., McCary, D. and Raffa, R. B. (1999). Response surface analysis of synergism between Morphine and Clonidine. Journal of Pharmacology and Experimental Therapeutics 289, 8-13.
32. Tallarida, R. J. (2001). Drug synergism: its detection and applications. Journal of Pharmacology and Experimental Therapeutics 298(3), 865-872.
33. Weinstein, J. N., Bunow, B., Weislow, O. S., Schinazi, F., Wahl, S. M., Wahl, L. M. and Szebeni, J. (1990). Synergistic drug combinations in AIDS therapy. Annals of the New York Academy of Science 616, 367-384.
34. White, D. B., Slocum, H. K., Brun, Y., Wrzosek, C., and Greco, W. R. (2003). A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example. Current Drug Metabolism 4, 399-409.
35. Yeap, Y. Y. and Davidian, M. (2001). Robust two-stage estimation in hierarchical linear models. Biometrics 57, 266-272.